Demonstrates cost-effectiveness in inflammatory bowel disease treatment, suggesting improved healthcare value.
NL-OMON21751. Website: Value-based healthcare for Inflammatory Bowel Disease: Improving (cost-) effectiveness.
No takes yet. Share an insight, caveat, or question.
Visser et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: